ACA
CGON icon

Acorn Capital Advisors’s CG Oncology CGON Stock Holding History

Acorn Capital Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.4M Buy
1,131,500
+999
+0.1% +$65.3K 21.94% 1
2026
Q1 		$76.6M Sell
1,130,501
-1,000
-0.1% -$56.7K 21.77% 2
2025
Q4 		$47M Hold
1,131,501
– – 15.92% 2
2025
Q3 		$45.6M Hold
1,131,501
– – 23.14% 1
2025
Q2 		$29.4M Hold
1,131,501
– – 19.24% 1
2025
Q1 		$27.7M Hold
1,131,501
– – 18.49% 1
2024
Q4 		$32.5M Buy
+1,131,501
New +$38.7M 17.46% 1

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acorn Capital Advisors's CGON Position: Q2 2026 in Review

Acorn Capital Advisors increased its CG Oncology (CGON) stake by 0.09% in Q2 2026, buying an estimated $65.3K and bringing the position to 1,131,500 shares worth $80.4M. The position accounts for 21.94% of the portfolio, ranked #1.

Acorn Capital Advisors first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Acorn Capital Advisors held 1,131,500 shares of CG Oncology worth $80.4M as of Q2 2026.
  • Acorn Capital Advisors bought 999 CG Oncology shares in Q2 2026, an estimated $65.3K.
  • CG Oncology made up 21.94% of Acorn Capital Advisors's portfolio in Q2 2026, its #1 holding.
  • Acorn Capital Advisors first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Acorn Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.